Alexander Dobbin

Alexander Dobbin is an experienced professional in investor relations and management, currently serving as Director at GRAIL, Inc. since May 2019. Prior roles include Head of Investor Relations at Theravance Biopharma US, Inc. from October 2016 to April 2019, and Associate Director of Investor Relations at Relypsa from December 2014 to October 2016. Alexander's expertise further encompasses a managerial position in Investor Relations at Onyx Pharmaceuticals in 2013, and Associate Director at Thomson Reuters from March 2008 to February 2013. Alexander's career initiated with service in the US Marine Corps from 2001 to 2005. Education includes a degree from Washington University in St. Louis - Olin Business School and attendance at The Head-Royce School.